We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Minimally Invasive Treatment for Ovarian Vein Reflux

By HospiMedica staff writers
Posted on 03 Jul 2003
A new catheter-based procedure treats ovarian vein reflux with embolization, which blocks the enlarged veins with small steel coils.

Ovarian vein reflux, also called pelvic congestion syndrome, is often undetected and untreated. More...
Among the causes are endometriosis, nerve conditions, pelvic support disorders, and trauma. In women with the condition, the valves in the pelvic veins fail to work properly, allowing blood to flow backward down into the pelvis. Gravity causes the blood to pool, stretching and enlarging the veins and causing dull pelvic pain, pressure, and heaviness.

Unlike varicose veins in the legs, varicose veins in the pelvis are difficult to see. Ultrasound or other imaging may not help to diagnose the condition because the patient is lying down and veins are apt to appear normal. Now, doctors are performing venography to diagnose the condition, a procedure in which a contrast solution is injected into the pelvic veins to enhance imaging and reveal abnormalities. When found, these are treated with embolization to block the enlarged veins with steel coils.

"Diagnosing ovarian vein reflux has been difficult, because we've lacked a noninvasive diagnostic tool capable of evaluating veins deep in the pelvis,” explained Anne C. Roberts, M.D., chief of vascular and interventional radiology at the University of California San Diego Medical Center (CA, USA). "In addition, physicians have not been trained to look for this condition.” Dr. Roberts spoke during a media briefing on image-guided therapies by the Radiological Society of North America (RSNA).




Related Links:
U. California, San Diego

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.